• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞培养中流感 A 病毒复制的多尺度建模预测了高度不同感染条件下的感染动力学。

Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions.

机构信息

Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.

Chair of Bioprocess Engineering, Institute of Process Engineering, Faculty of Process & Systems Engineering, Otto-von-Guericke University, Magdeburg, Germany.

出版信息

PLoS Comput Biol. 2019 Feb 19;15(2):e1006819. doi: 10.1371/journal.pcbi.1006819. eCollection 2019 Feb.

DOI:10.1371/journal.pcbi.1006819
PMID:30779733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6396949/
Abstract

Influenza A viruses (IAV) are commonly used to infect animal cell cultures for research purposes and vaccine production. Their replication is influenced strongly by the multiplicity of infection (MOI), which ranges over several orders of magnitude depending on the respective application. So far, mathematical models of IAV replication have paid little attention to the impact of the MOI on infection dynamics and virus yields. To address this issue, we extended an existing model of IAV replication in adherent MDCK cells with kinetics that explicitly consider the time point of cell infection. This modification does not only enable the fitting of high MOI measurements, but also the successful prediction of viral release dynamics of low MOI experiments using the same set of parameters. Furthermore, this model allows the investigation of defective interfering particle (DIP) propagation in different MOI regimes. The key difference between high and low MOI conditions is the percentage of infectious virions among the total virus particle release. Simulation studies show that DIP interference at a high MOI is determined exclusively by the DIP content of the seed virus while, in low MOI conditions, it is predominantly controlled by the de novo generation of DIPs. Overall, the extended model provides an ideal framework for the prediction and optimization of cell culture-derived IAV manufacturing and the production of DIPs for therapeutic use.

摘要

甲型流感病毒(IAV)常用于感染动物细胞培养物进行研究和疫苗生产。它们的复制受感染复数(MOI)的强烈影响,MOI 范围根据各自的应用而异,跨越几个数量级。到目前为止,IAV 复制的数学模型很少关注 MOI 对感染动力学和病毒产量的影响。为了解决这个问题,我们用明确考虑细胞感染时间点的动力学扩展了一个现有的贴壁 MDCK 细胞中 IAV 复制的模型。这种修改不仅能够拟合高 MOI 测量值,而且还能够使用相同的参数集成功预测低 MOI 实验的病毒释放动力学。此外,该模型还可以研究不同 MOI 下缺陷干扰颗粒(DIP)的传播。高 MOI 和低 MOI 条件之间的关键区别在于总病毒粒子释放中传染性病毒粒子的百分比。模拟研究表明,高 MOI 下的 DIP 干扰仅由种子病毒中的 DIP 含量决定,而在低 MOI 条件下,DIP 干扰主要由 DIP 的从头产生控制。总体而言,扩展模型为预测和优化细胞培养衍生的 IAV 制造以及用于治疗用途的 DIP 生产提供了理想的框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/a036e0df2799/pcbi.1006819.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/a55891940734/pcbi.1006819.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/3947aba39ff9/pcbi.1006819.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/7a7d355eda8e/pcbi.1006819.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/502c0b766519/pcbi.1006819.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/423d18435cba/pcbi.1006819.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/a036e0df2799/pcbi.1006819.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/a55891940734/pcbi.1006819.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/3947aba39ff9/pcbi.1006819.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/7a7d355eda8e/pcbi.1006819.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/502c0b766519/pcbi.1006819.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/423d18435cba/pcbi.1006819.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad07/6396949/a036e0df2799/pcbi.1006819.g006.jpg

相似文献

1
Multiscale modeling of influenza A virus replication in cell cultures predicts infection dynamics for highly different infection conditions.细胞培养中流感 A 病毒复制的多尺度建模预测了高度不同感染条件下的感染动力学。
PLoS Comput Biol. 2019 Feb 19;15(2):e1006819. doi: 10.1371/journal.pcbi.1006819. eCollection 2019 Feb.
2
Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture.动物细胞培养中甲型流感病毒感染的缺陷干扰粒子复制的多尺度模型。
PLoS Comput Biol. 2021 Sep 7;17(9):e1009357. doi: 10.1371/journal.pcbi.1009357. eCollection 2021 Sep.
3
Cellular co-infection can modulate the efficiency of influenza A virus production and shape the interferon response.细胞的共感染可以调节甲型流感病毒的产生效率,并影响干扰素反应。
PLoS Pathog. 2020 Oct 16;16(10):e1008974. doi: 10.1371/journal.ppat.1008974. eCollection 2020 Oct.
4
Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.季节性流感病毒对小鼠巨噬细胞的感染可在病毒进入阶段以及病毒生命周期的后期受到限制。
J Virol. 2015 Dec;89(24):12319-29. doi: 10.1128/JVI.01455-15. Epub 2015 Sep 30.
5
Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants.甲型流感病毒 A/PR/8 株及其基于重配的重组株的生产能力、细胞凋亡和感染动力学。
Vaccine. 2012 Jul 27;30(35):5253-61. doi: 10.1016/j.vaccine.2012.05.065. Epub 2012 Jun 12.
6
Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.缺陷干扰颗粒对基于细胞培养的流感疫苗生产中病毒复制和抗病毒宿主反应的影响。
Appl Microbiol Biotechnol. 2014 Nov;98(21):8999-9008. doi: 10.1007/s00253-014-5933-y. Epub 2014 Aug 19.
7
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.甲型流感病毒及其缺陷干扰颗粒的半连续繁殖:分析动态竞争以选择抗病毒治疗候选物。
J Virol. 2021 Nov 23;95(24):e0117421. doi: 10.1128/JVI.01174-21. Epub 2021 Sep 22.
8
Mathematical model of influenza A virus production in large-scale microcarrier culture.甲型流感病毒在大规模微载体培养中的数学模型
Biotechnol Bioeng. 2005 Apr 5;90(1):46-58. doi: 10.1002/bit.20363.
9
A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.一种具有基因组核苷酸替换的新型甲型流感病毒来源的缺陷干扰颗粒。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01786-18. Print 2019 Feb 15.
10
Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times-Insights From qPCR Measurements and Viral Dynamics Modeling.在两种停留时间下的平行连续培养中甲型流感病毒缺陷干扰颗粒的产生——来自定量聚合酶链反应测量和病毒动力学建模的见解
Front Bioeng Biotechnol. 2019 Oct 18;7:275. doi: 10.3389/fbioe.2019.00275. eCollection 2019.

引用本文的文献

1
Intracellular replication dynamics of influenza A virus impose strong bottleneck effects.甲型流感病毒的细胞内复制动态产生强大的瓶颈效应。
bioRxiv. 2025 Jul 19:2025.07.18.665558. doi: 10.1101/2025.07.18.665558.
2
Quantification of intracellular influenza A virus protein dynamics in different host cells after seed virus adaptation.种子病毒适应后不同宿主细胞内甲型流感病毒蛋白动力学的定量分析
Appl Microbiol Biotechnol. 2025 Mar 24;109(1):74. doi: 10.1007/s00253-025-13423-3.
3
Continuous Production of Influenza VLPs Using IC-BEVS and Multi-Stage Bioreactors.

本文引用的文献

1
A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.一种具有基因组核苷酸替换的新型甲型流感病毒来源的缺陷干扰颗粒。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01786-18. Print 2019 Feb 15.
2
Cell culture-based production of defective interfering particles for influenza antiviral therapy.基于细胞培养生产缺陷干扰颗粒用于流感抗病毒治疗。
Appl Microbiol Biotechnol. 2018 Feb;102(3):1167-1177. doi: 10.1007/s00253-017-8660-3. Epub 2017 Dec 5.
3
Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors.
使用昆虫细胞杆状病毒表达系统(IC-BEVS)和多级生物反应器连续生产流感病毒样颗粒(VLPs)
Biotechnol Bioeng. 2025 Apr;122(4):846-857. doi: 10.1002/bit.28925. Epub 2025 Jan 17.
4
Parallel Multifactorial Process Optimization and Intensification for High-Yield Production of Live YF17D-Vectored Zika Vaccine.用于高产活YF17D载体寨卡疫苗的并行多因素工艺优化与强化
Vaccines (Basel). 2024 Jul 9;12(7):755. doi: 10.3390/vaccines12070755.
5
Innovations in cell culture-based influenza vaccine manufacturing - from static cultures to high cell density cultivations.基于细胞培养的流感疫苗制造创新——从静态培养到高密度培养。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2373521. doi: 10.1080/21645515.2024.2373521. Epub 2024 Jul 15.
6
Mathematical model calibrated to data predicts mechanisms of antiviral action of the influenza defective interfering particle "OP7".根据数据校准的数学模型预测了流感缺陷干扰颗粒“OP7”的抗病毒作用机制。
iScience. 2024 Mar 5;27(4):109421. doi: 10.1016/j.isci.2024.109421. eCollection 2024 Apr 19.
7
Generation of "OP7 chimera" defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice.生成无感染性病毒的“OP7 嵌合体”缺陷型干扰流感 A 粒子制剂,在小鼠中显示抗病毒功效。
Sci Rep. 2023 Nov 28;13(1):20936. doi: 10.1038/s41598-023-47547-1.
8
Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro.甲型流感缺陷干扰颗粒对呼吸道合胞病毒、黄热病病毒和寨卡病毒复制的广谱抗病毒活性的研究。
Viruses. 2023 Sep 4;15(9):1872. doi: 10.3390/v15091872.
9
Multiscale Asymptotic Analysis Reveals How Cell Growth and Subcellular Compartments Affect Tissue-Scale Hormone Transport.多尺度渐近分析揭示了细胞生长和亚细胞区室如何影响组织尺度的激素运输。
Bull Math Biol. 2023 Sep 13;85(10):101. doi: 10.1007/s11538-023-01199-4.
10
SARS-CoV-2 leverages airway epithelial protective mechanism for viral infection.严重急性呼吸综合征冠状病毒2利用气道上皮保护机制进行病毒感染。
iScience. 2023 Mar 17;26(3):106175. doi: 10.1016/j.isci.2023.106175. Epub 2023 Feb 10.
探索病毒释放作为甲型流感病毒体外感染传播的瓶颈以及对神经氨酸酶抑制剂抗病毒治疗的影响。
PLoS One. 2017 Aug 24;12(8):e0183621. doi: 10.1371/journal.pone.0183621. eCollection 2017.
4
Viral RNA Degradation and Diffusion Act as a Bottleneck for the Influenza A Virus Infection Efficiency.病毒RNA降解与扩散成为甲型流感病毒感染效率的瓶颈。
PLoS Comput Biol. 2016 Oct 25;12(10):e1005075. doi: 10.1371/journal.pcbi.1005075. eCollection 2016 Oct.
5
Spatial-Temporal Patterns of Viral Amplification and Interference Initiated by a Single Infected Cell.单个感染细胞引发的病毒扩增和干扰的时空模式。
J Virol. 2016 Jul 27;90(16):7552-7566. doi: 10.1128/JVI.00807-16. Print 2016 Aug 15.
6
Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells.流感病毒在MDCK细胞中增殖期间的细胞内复制动力学、释放动力学及颗粒形态。
Appl Microbiol Biotechnol. 2016 Aug;100(16):7181-92. doi: 10.1007/s00253-016-7542-4. Epub 2016 Apr 29.
7
RNA-Free and Ribonucleoprotein-Associated Influenza Virus Polymerases Directly Bind the Serine-5-Phosphorylated Carboxyl-Terminal Domain of Host RNA Polymerase II.无RNA且与核糖核蛋白相关的流感病毒聚合酶直接结合宿主RNA聚合酶II的丝氨酸5磷酸化羧基末端结构域。
J Virol. 2016 Jun 10;90(13):6014-6021. doi: 10.1128/JVI.00494-16. Print 2016 Jul 1.
8
High-Throughput Single-Cell Kinetics of Virus Infections in the Presence of Defective Interfering Particles.存在缺陷干扰颗粒时病毒感染的高通量单细胞动力学
J Virol. 2015 Nov 25;90(3):1599-612. doi: 10.1128/JVI.02190-15. Print 2016 Feb 1.
9
Modeling the intracellular replication of influenza A virus in the presence of defective interfering RNAs.在缺陷干扰 RNA 存在的情况下模拟甲型流感病毒的细胞内复制。
Virus Res. 2016 Feb 2;213:90-99. doi: 10.1016/j.virusres.2015.11.016. Epub 2015 Nov 23.
10
Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection.单细胞分析与随机建模揭示甲型流感病毒感染中细胞间存在巨大变异性。
Nat Commun. 2015 Nov 20;6:8938. doi: 10.1038/ncomms9938.